comparemela.com

Researchers at Children's Hospital of Philadelphia (CHOP) have developed a proof-of-concept treatment for blood disorders like sickle cell disease and beta-thalassemia that could raise hemoglobin levels by activating production of both fetal and adult hemoglobin. Using a viral vector engineered to reactivate fetal hemoglobin production, suppress mutant hemoglobin, and supply functional adult hemoglobin, the researchers developed an approach that could produce more hemoglobin through a single vector. The results were published in Haematologica.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Silvia Lourenco ,Kwame Ohene Frempong ,Stefano Rivella ,Danuta Jarocha ,Frontier Program ,Kwame Ohene Frempong Chair ,Sickle Cell Anemia ,Medicine Health ,Hematology ,Ediatrics ,பிலடெல்பியா ,பென்சில்வேனியா ,ஒன்றுபட்டது மாநிலங்களில் ,எல்லை ப்ரோக்ர்யாம் ,அரிவாள் செல் இரத்த சோகை ,மருந்து ஆரோக்கியம் ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.